CEF27,Epstein-Barr Virus BRLF-1 lytic 148-156
CAS No. 254110-79-7
CEF27,Epstein-Barr Virus BRLF-1 lytic 148-156( —— )
Catalog No. M29966 CAS No. 254110-79-7
HLA-A*0301-restricted epitope from Epstein-Barr Virus , EBV BRLF-1 (148-156).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameCEF27,Epstein-Barr Virus BRLF-1 lytic 148-156
-
NoteResearch use only, not for human use.
-
Brief DescriptionHLA-A*0301-restricted epitope from Epstein-Barr Virus , EBV BRLF-1 (148-156).
-
DescriptionHLA-A*0301-restricted epitope from Epstein-Barr Virus , EBV BRLF-1 (148-156).(In Vitro):Expression of the EBV immediate-early (IE) protein BRLF1 induces the lytic form of viral replication in most EBV-positive cell lines.
-
In VitroExpression of the EBV immediate-early (IE) protein BRLF1 induces the lytic form of viral replication in most EBV-positive cell lines.
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number254110-79-7
-
Formula Weight302.93
-
Molecular FormulaTKSVY2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical NameSequence:{Arg}{Val}{Arg}{Ala}{Tyr}{Thr}{Tyr}{Ser}{Lys}
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
N-phenylacetyl-L-Hom...
N-phenylacetyl-L-Homoserine lactone attenuates the group sensing of the pathogen Acinetobacter baumannii and can be used to study bacterial infections.
-
Dynamin inhibitory p...
Control peptide version of dynamin inhibitory peptide, myristoylated, an inhibitor of the GTPase dynamin that competitively blocks binding of dynamin to amphiphysin, preventing endocytosis. In contrast to dynamin inhibitory peptide, has no significant effect on GABAA receptor-mediated miniature IPSPs.
-
CGP 20376
CGP 20376 is a benzothiazole compound, an anthelmintic, with dual dose-dependent modulation of in vitro effects on the respiratory burst of eosinophils and antifibrillatory properties.
Cart
sales@molnova.com